166 related articles for article (PubMed ID: 37658212)
1. Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Hu S; Trieb M; Huang R; Tamalunas A; Keller P; Götz M; Waidelich R; Stief CG; Hennenberg M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1219-1231. PubMed ID: 37658212
[TBL] [Abstract][Full Text] [Related]
2. The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor.
Li B; Wang X; Rutz B; Wang R; Tamalunas A; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):829-842. PubMed ID: 31867686
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gα
Tamalunas A; Wendt A; Springer F; Ciotkowska A; Rutz B; Wang R; Huang R; Liu Y; Schulz H; Ledderose S; Magistro G; Stief CG; Hennenberg M
Front Physiol; 2022; 13():884057. PubMed ID: 35677088
[No Abstract] [Full Text] [Related]
4. Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.
Huang R; Liu Y; Li B; Wang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
Prostate; 2022 Jan; 82(1):59-77. PubMed ID: 34633103
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of neurogenic, but not agonist-induced contractions by phospholipase A
Hu S; Huang R; Keller P; Götz M; Tamalunas A; Weinhold P; Waidelich R; Stief CG; Hennenberg M
Neurourol Urodyn; 2023 Sep; 42(7):1522-1531. PubMed ID: 37583250
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neurogenic and thromboxane A
Li B; Wang X; Wang R; Rutz B; Ciotkowska A; Gratzke C; Herlemann A; Spek A; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
Prostate; 2020 Aug; 80(11):831-849. PubMed ID: 32449814
[TBL] [Abstract][Full Text] [Related]
7. Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α
Wang X; Li B; Ciotkowska A; Rutz B; Erlander MG; Ridinger M; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
Eur J Pharmacol; 2020 Apr; 873():172985. PubMed ID: 32017934
[TBL] [Abstract][Full Text] [Related]
8. Concentration-dependent alpha
Huang R; Liu Y; Ciotkowska A; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
Front Pharmacol; 2021; 12():666047. PubMed ID: 34248624
[No Abstract] [Full Text] [Related]
9. Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729.
Huang R; Li B; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):471-485. PubMed ID: 35141760
[TBL] [Abstract][Full Text] [Related]
10. New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.
Yu Q; Gratzke C; Wang Y; Wang X; Li B; Strittmatter F; Herlemann A; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
Prostate; 2019 May; 79(7):746-756. PubMed ID: 30811062
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of α
Huang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
Biochem Pharmacol; 2022 Aug; 202():115148. PubMed ID: 35716783
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
Hennenberg M; Tamalunas A; Wang Y; Keller P; Schott M; Strittmatter F; Herlemann A; Yu Q; Rutz B; Ciotkowska A; Stief CG; Gratzke C
Eur J Pharmacol; 2017 May; 803():39-47. PubMed ID: 28315343
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?
Tamalunas A; Sauckel C; Ciotkowska A; Rutz B; Wang R; Huang R; Li B; Stief CG; Gratzke C; Hennenberg M
Prostate; 2021 May; 81(7):377-389. PubMed ID: 33687083
[TBL] [Abstract][Full Text] [Related]
14. Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.
Li B; Huang R; Wang R; Liu Y; Stief CG; Hennenberg M
Pharmacol Res Perspect; 2021 May; 9(3):e00771. PubMed ID: 33929093
[TBL] [Abstract][Full Text] [Related]
15. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α
Hennenberg M; Acevedo A; Wiemer N; Kan A; Tamalunas A; Wang Y; Yu Q; Rutz B; Ciotkowska A; Herlemann A; Strittmatter F; Stief CG; Gratzke C
Prostate; 2017 May; 77(7):697-707. PubMed ID: 28116771
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.
Hennenberg M; Kuppermann P; Yu Q; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Strittmatter F; Stief CG; Gratzke C
Front Physiol; 2018; 9():734. PubMed ID: 29962965
[No Abstract] [Full Text] [Related]
17. Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.
Hennenberg M; Schott M; Kan A; Keller P; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Strittmatter F; Herlemann A; Yu Q; Stief CG; Gratzke C
Prostate; 2016 Nov; 76(15):1364-74. PubMed ID: 27418235
[TBL] [Abstract][Full Text] [Related]
18. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766.
Li B; Yu Q; Wang R; Gratzke C; Wang X; Spek A; Herlemann A; Tamalunas A; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
Front Pharmacol; 2020; 11():409. PubMed ID: 32317972
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.
Yu Q; Gratzke C; Wang Y; Herlemann A; Strittmatter F; Rutz B; Stief CG; Hennenberg M
Eur J Pharmacol; 2018 Jul; 831():9-19. PubMed ID: 29698717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
